Meprin β regulates osteopontin-signaling in ischemia/reperfusion-induced kidney injury

Faihaa Ahmed1,2, Shaymaa Abousaad1, Ayman Abouzeid3

  • 1Department of Kinesiology, North Carolina A&T State University, Greensboro, NC, 27411, USA.

BMC Nephrology
|February 22, 2025
PubMed
Abstract

Insights

Meprin beta influences osteopontin (OPN) levels and related apoptosis pathways in kidney injury. Its absence alters OPN distribution and downstream signaling in ischemia/reperfusion injury models.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathology

Background:

  • Meprin metalloproteases are implicated in kidney injury.
  • Meprin beta processes signaling mediators involved in apoptosis and ECM metabolism.
  • Meprin beta cleaves osteopontin (OPN).

Purpose of the Study:

  • To determine how meprin beta expression affects OPN and downstream mediators in kidney injury.
  • Investigate the role of meprin beta in the OPN signaling pathway during ischemia/reperfusion (IR).

Main Methods:

  • Ischemia/Reperfusion (IR) injury induced in wild-type and meprin beta knockout mice.
  • Quantification of OPN, Caspase-3, Bcl-2, and NFκB using PCR, western blot, and immunohistochemistry.
  • Statistical analysis using 2-way ANOVA and unpaired t-tests.

Main Results:

  • OPN mRNA and protein levels increased post-IR in both genotypes.
  • Higher OPN levels in proximal tubule lumens of wild-type mice suggest meprin beta enhances OPN release into filtrate.
  • Increased Caspase-3 and NFκB in wild-type tubules; Bcl-2 increased in both genotypes post-IR.

Conclusions:

  • Meprin beta modulates OPN levels in IR-induced kidney injury.
  • Meprin beta influences apoptotic genes regulated by the OPN signaling pathway.

Related Concept Videos